Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, slowing the progression of the disease and managing symptoms. Relapsing-remitting MS has certain medications which can lower the relapse rate and also formation of new lesions in early disease course. But no therapies have shown benefit for slowing the progression of primary-progressive MS. Certain disease-modifying drugs have been shown to reduce exacerbations and slow the progression of MS. Of which (Interferon drugs and Copaxone) are considered to be very safe. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under research.
Related Multiple Sclerosis Medications
Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Multiple Sclerosis, Multiple Sclerosis and Related Disorders, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorders